<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01332825</url>
  </required_header>
  <id_info>
    <org_study_id>39352-A</org_study_id>
    <nct_id>NCT01332825</nct_id>
  </id_info>
  <brief_title>cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose</brief_title>
  <official_title>cAMP Levels in the Nose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the normal distribution of nasal tissue&#xD;
      cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects&#xD;
      with smell dysfunction. The investigators will also look at the effect of nasal saline&#xD;
      irrigation on olfaction and cAMP levels and if nasal irrigation is capable of harvesting&#xD;
      olfactory cilia. The investigators hypothesize that nasal saline will have no effect on&#xD;
      olfaction and will be inadequate to harvest olfactory cilia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit 40 subjects: 10 with olfactory dysfunction and 30 with normal&#xD;
      olfaction. The normal olfaction group will be randomized (15-15)to either daily saline nasal&#xD;
      irrigation for one week or no irrigation. Normal olfaction subjects will be seen for two&#xD;
      visits, olfactory dysfunction for one. All subjects will complete an UPSIT (smell&#xD;
      identification test)and a co-morbidity form. All subjects will have a brief nasal exam and&#xD;
      then have nasal cells collected by means of a curette on one side and a cytobrush on the&#xD;
      other. All subjects will receive Afrin and lidocaine, to improve visualization and for&#xD;
      comfort during cell collection. Subjects will then complete a Comfort Scale related to the&#xD;
      methods of cell collection. Normal olfaction subjects randomized to nasal irrigation will&#xD;
      receive instructions on how to do it and the irrigation results will be collected for&#xD;
      analysis along with the nasal cells. At their return visit, normal olfaction subjects will&#xD;
      repeat the UPSIT and the comfort scale--all normal olfaction subjects will have a repeat cell&#xD;
      collection. Subjects randomized to nasal irrigation will also complete a transition scale&#xD;
      which asks if they feel the irrigation made a difference in their sense of smell. Subjects&#xD;
      are compensated for time with a gift card.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>UPSIT</measure>
    <time_frame>7 days</time_frame>
    <description>validated, scratch and sniff smell identification test</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Olfactory Disorder</condition>
  <arm_group>
    <arm_group_label>olfactory dysfunction</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>subjects diagnosed with olfactory dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal olfaction, no saline</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no smell dysfunction, not randomized to saline nasal irrigation for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal olfaction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>normal olfaction, randomized to saline nasal irrigation for 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline nasal irrigation</intervention_name>
    <description>subjects irrigate with nasal saline daily for one week</description>
    <arm_group_label>normal olfaction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Normal olfactory function cohort:&#xD;
&#xD;
          -  self-reported normal smell function&#xD;
&#xD;
          -  age greater than 18 years&#xD;
&#xD;
        Olfactory dysfunction cohort:&#xD;
&#xD;
          -  ICD9 diagnostic code for olfactory dysfunction&#xD;
&#xD;
          -  idiopathic olfactory dysfunction&#xD;
&#xD;
          -  age greater than 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergy to lidocaine&#xD;
&#xD;
          -  active upper respiratory infection&#xD;
&#xD;
          -  previous nasal or sinus surgery&#xD;
&#xD;
          -  current tobacco use&#xD;
&#xD;
          -  unable to give consent due to language barrier, cognitive or medical issues&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Greg E Davis, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>April 7, 2011</study_first_submitted>
  <study_first_submitted_qc>April 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2011</study_first_posted>
  <last_update_submitted>December 11, 2013</last_update_submitted>
  <last_update_submitted_qc>December 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Greg Davis</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>olfaction</keyword>
  <keyword>smell dysfunction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

